Difference between revisions of "Piritramide"
From WikiAnesthesia
(added brand name) |
m |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{Infobox drug reference | |||
| trade_names = | |||
| drug_class = synthetic opioid | |||
| drug_class_color = | |||
| uses = | |||
| contraindications = | |||
| routes = IV and IM | |||
| dosage = | |||
}} | |||
Brand name: Dipidolor | |||
== Uses<!-- Describe uses of the drug. If appropriate, add subsections for each indication. --> == | |||
== Contraindications<!-- List contraindications and precautions for use of the drug. --> == | |||
=== Absolute contraindications<!-- List absolute contraindications for use of the drug. If none, this section may be removed. --> === | |||
=== Precautions<!-- List precautions for use of the drug. If none, this section may be removed. --> === | |||
== Pharmacology == | |||
=== Pharmacodynamics<!-- Describe the effects of the drug on the body. If appropriate, add subsections by organ system --> === | |||
==== Mechanism of action<!-- Describe the mechanism of action for the primary uses of the drug. --> ==== | |||
==== Adverse effects<!-- Describe any potential adverse effects of the drug. --> ==== | |||
=== Pharmacokinetics<!-- Describe the pharmacokinetics of the drug. --> === | |||
== Chemistry and formulation<!-- Describe the chemistry and formulation of the drug. --> == | |||
== History<!-- Describe the historical development of the drug. --> == | |||
== References == | |||
[[Category:Drug reference]] |
Latest revision as of 08:13, 29 January 2023
Piritramide
Clinical data | |
Drug class |
synthetic opioid |
---|---|
Routes of administration |
IV and IM |
Pharmacodynamics | |
Pharmacokinetics | |
Physical and chemical data | |
Article quality | |
Editor rating | |
User likes | 0 |
Brand name: Dipidolor
Uses
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Tony Wang and rikcarette@yahoo.com